JHB - $JHB STOCK NEWS

Welcome to our dedicated page for JHB news (Ticker: $JHB), a resource for investors and traders seeking the latest updates and insights on JHB stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JHB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JHB's position in the market.

11/02/2021 11:24 AM

News

Nuveen Corporate Income November 2021 Target Term Fund Announces Termination and Liquidation

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

NYSE:JHB

JHB Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

JHB Stock Data

Market Cap 0

Float 0

Website Link

Country US

City Chicago

About JHB

Nuveen Corporate Income November 2021 Target Term Fund seeks to provide a high level of current income and return the original $9.85 net asset value per common share on or about 1 Nov 2021.* The Fund invests in a portfolio of primarily corporate debt securities. The Fund may invest in other types of securities including senior loans, convertible securities and other types of debt instruments and derivatives that provide comparable economic exposure to the corporate debt market. At least 80% of its managed assets will be in corporate debt securities. No more than 15% will be in securities rated CCC+/Caa1 or lower at the time of investment. Up to 30% may be in securities of non-U.S. issuers, including up to 20% in emerging market issuers, and up to 10% may be in non-U.S. dollar denominated securities. The Fund seeks to identify securities across diverse sectors and industries that the managers believe are undervalued or mispriced. In seeking to return the original NAV on or about 1 Nov 2021, the Fund intends to utilize various portfolio and cash flow management techniques, including setting aside a portion of its net investment income, possibly retaining gains and limiting the longest maturity of any holding to no later than 1 May 2022. The Fund uses leverage.